Luke Fritz
Ambassador Spotlight

Meet TrialNet Ambassador Luke Fritz: Type 1 Dad and Research Advocate

When Luke Fritz read about the Ambassador Program in TrialNet’s e-newsletter, he immediately recognized the connection to his personal mission: guiding people with type 1 diabetes (T1D) to reliable, evidence-based resources.

 

“When you're facing a new diagnosis and searching for answers, connecting with people who have walked in your shoes makes a huge difference,” Luke says.

 

Luke is one of more than 100 TrialNet Ambassadors championing the vital role of T1D clinical research. Equipped with the Ambassador Toolkit, Ambassadors raise awareness across their networks—promoting early T1D risk screening and innovative studies aimed at slowing disease progression.

 

The Ambassador Program recently unveiled a new badge designed to align with TrialNet’s 25th Anniversary celebration. Ambassadors display the badge on their platforms to highlight their partnership with TrialNet and their commitment to advancing T1D research.

 

From Misdiagnosis to Advocacy

 

Luke’s passion for advocacy grew directly out of his personal experience. In October 2020, after experiencing severe fatigue and weight loss, he was initially misdiagnosed with type 2 diabetes.

“I was 25, active, and had no family history of type 2 diabetes,” Luke recalls. “Things just didn't line up.”

 

Seeking clarity, he consulted an endocrinologist who performed autoantibody testing and confirmed a T1D diagnosis. “My experience highlighted the critical need for specialized care and better public education surrounding adult-onset of T1D,” he explains.

 

Wanting to connect with others with T1D without overwhelming his personal network, Luke launched @type_1dad on Instagram. As a father of two toddlers, he uses the platform to share the daily realities of managing T1D alongside parenthood, his career as a geologist, and hobbies like hiking and riding his motorcycle.

 

Luke enjoys spending time outdoors with his family, hiking, riding his motorcycle, and cooking on the smoker.

 

Connecting with TrialNet Research

                                                                                       

Shortly after his diagnosis, Luke began researching clinical trials. His search led him to Dorothy Becker, MD, at UPMC Children’s Hospital of Pittsburgh—one of 17 TrialNet Clinical Centers at the forefront of T1D research. In early 2022, he enrolled in TrialNet’s Tolerance Using Plasmid (TOPPLE) Study, a phase 1 study evaluating the safety and dosing of a plasmid immunotherapy in individuals recently diagnosed with T1D. 

 

“Participating in the TOPPLE study helped me become more structured in my diabetes management,” Luke says. “From Dr. Becker to the nurses and trial coordinators, the team eased my anxiety and empowered me with knowledge when I needed it most.”

 

When the TOPPLE Study ended, Luke joined the Long Term Investigative Follow-up in TrialNet (LIFT) Study. LIFT is the only clinical study in the world that follows people with T1D before, during, and after diagnosis.

Through TrialNet, Luke also learned about the importance of risk screening and had his sons screened for T1D autoantibodies. While both tested negative, he plans to screen them regularly, knowing autoantibody status can change over time.

 

Earlier this year, Luke also joined TrialNet’s Community Advisory Board (CAB), where he provides input on upcoming study designs and communications.

 

Reflecting on his journey, Luke credits TrialNet with transforming his outlook. “TrialNet helped me understand and accept T1D in my life. The people involved are genuinely there to help.”

Luke’s TrialNet Journey

2022: Enrolled in TOPPLE Study

2024: Screened first son for T1D risk

2025: Enrolled in LIFT Study

2026: Joined Ambassador Program

2026: Joined Community Advisory Board

2026: Screened second son for T1D risk

Luke Fritz launched his Instagram page @type_1dad to share the realities of balancing a career and parenting with T1D.

You Can Become a TrialNet Ambassador too!

If you’re passionate about the future of type 1 diabetes (T1D) research, TrialNet invites you to join our Ambassador Program. Ambassadors help spread awareness about TrialNet risk screening and clinical studies. 

 

Whether you’re a student, blogger, parent, member of a nonprofit, social media influencer, you can become a TrialNet Ambassador. Our Ambassador Toolkit provides everything you need to help spread the word about TrialNet research. 

 

Learn more about becoming a TrialNet Ambassador and sign up here. When we receive your registration form, we’ll send you a confirmation email along with your Ambassador Toolkit. If you have any questions, contact us at info@trialnet.org.

 

Sign up here to join our mailing list for the latest updates on important T1D research and events, straight to your inbox. You can also find us on Facebook @DiabetesTrialNet.